Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha and Thalidomide in Metastatic Renal Cell Carcinoma
NCT00027664Phase 2Unknown
- Sponsor
- Cancer Research UK
- Start
- Feb 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in renal cell carcinoma (RCC), sponsored by Cancer Research UK. Status: unknown.
02
Drugs
thalidomide
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00027664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027664.